查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1766320

兽医参考实验室市场机会、成长动力、产业趋势分析及 2025 - 2034 年预测

Veterinary Reference Laboratory Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034
出版日期: | 出版商: Global Market Insights Inc. | 英文 136 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2024年，全球兽医参考实验室市场规模达49亿美元，预计到2034年将以10.6%的复合年增长率成长，达到133亿美元。这一增长的主要驱动力是农场动物和伴侣动物中慢性病和人畜共患疾病发生率的上升。疾病负担的增加引发了对诊断服务的需求增长，尤其是随着宠物主人对糖尿病、癌症和寄生虫感染等疾病早期诊断意识的不断增强。在畜牧业，食品安全和动物健康的更严格要求进一步鼓励了先进检测服务的采用。

兽医参考实验室市场 - IMG1

在以改善动物健康管理为核心的监管措施的推动下，公共和私人投资正在推动诊断基础设施的发展。兽医诊断实验室网路的不断扩大以及诊所和参考机构之间日益加强的合作，有助于将服务拓展到先前服务不足的市场。此外，宠物保险覆盖率的提高，使得宠物主人能够更经济地接受兽医诊断，从而提高了参考实验室服务的利用率，并加速了已开发经济体和新兴经济体市场的发展势头。

市场范围
起始年份 2024
预测年份 2025-2034
起始值 49亿美元
预测值 133亿美元
复合年增长率 10.6%

2024年，临床化学领域的估值达到18亿美元，这得归功于这些检测在血液和体液分析中所扮演的关键角色。这些检测对于评估内臟器官功能、电解质水平和整体代谢状态至关重要。它们对于检测宠物和牲畜的慢性疾病（例如肾臟疾病、糖尿病和内分泌疾病）尤其重要。自动化高通量分析仪在参考实验室中的应用日益增多，有助于快速提供准确的结果，满足了日益增长的常规和紧急诊断服务需求。

临床病理学领域在2024年占了34.6%的市场份额，并将继续成为兽医诊断的基石。该领域包括血液学、细胞学、尿液分析和化学检测等重要服务，有助于识别动物的各种疾病状况。临床病理学是兽医医疗保健的第一线评估，为从常规健康监测到复杂疾病的诊断等各个方面提供帮助。随着慢性病和传染病的日益普遍，临床和预防保健领域对这些检测在动物健康管理中的依赖性也日益增强。

2024年，美国兽医参考实验室市场规模达17亿美元。其成长主要得益于高宠物拥有率、不断增长的兽医支出以及现代动物照护服务的普及。美国完善的兽医基础设施以及宠物保险的广泛普及，正在鼓励人们更频繁地进行诊断检测。这种环境支持了美国先进参考实验室服务的扩张，并对整个市场做出了重大贡献。

全球兽医参考实验室市场的主要参与者包括 Zoetis、Heska Corporation、IDEXX Laboratories、Thermo Fisher Scientific、Antech Diagnostics (Mars)、Virbac、Nova Biomedical、Vaxxinova、Boehringer Ingelheim International、Laboklin、GD Animal Health、Neogen Corporation 和科罗拉多州立大学。为了巩固其在兽医参考实验室市场的地位，各公司正在实施一系列策略性措施。这些措施包括扩大实验室网络并与兽医诊所建立策略合作伙伴关係以提高服务的可及性。许多公司也正在投资下一代诊断工具和自动化，以提供更快、更准确的结果。透过收购和在地化服务开拓新兴市场，使他们能够接触到更多客户，同时提高营运的可扩展性。

目录

第一章：方法论与范围

第二章：执行摘要

第三章：行业洞察

  • 产业生态系统分析
    • 供应商格局
    • 每个阶段的增值
    • 影响价值链的因素
  • 产业衝击力
    • 成长动力
      • 越来越多人收养宠物作为陪伴
      • 宠物保险普及率上升，动物保健支出增加
      • 宠物中人畜共通传染病数量不断增加
    • 产业陷阱与挑战
      • 诊断服务成本高昂
      • POC便携式仪器的需求不断成长
    • 机会
      • 向新兴市场扩张
      • 牲畜和食品安全检测需求不断增长
  • 成长潜力分析
  • 监管格局
  • 技术和创新格局
    • 当前的技术趋势
    • 新兴技术
  • 未来市场趋势
  • 波特的分析
  • PESTEL分析

第四章：竞争格局

  • 介绍
  • 公司市占率分析
  • 公司矩阵分析
  • 主要市场参与者的竞争分析
  • 竞争定位矩阵
  • 关键进展
    • 併购
    • 伙伴关係和合作
    • 新产品发布
    • 扩张计划

第五章：市场估计与预测：按技术，2021 年至 2034 年

  • 主要趋势
  • 临床化学
  • 免疫诊断
    • 酵素连结免疫吸附试验
    • 横向流动试验
    • 其他免疫诊断检测
  • 分子诊断
    • PCR检测
    • 微阵列
    • 其他分子诊断服务
  • 血液学
  • 尿液分析
  • 其他技术

第六章：市场估计与预测：按应用，2021 年至 2034 年

  • 主要趋势
  • 临床病理学
  • 细菌学
  • 病毒学
  • 寄生虫学
  • 生产力测试
  • 妊娠测试
  • 毒理学测试

第七章：市场估计与预测：依动物类型，2021 年至 2034 年

  • 主要趋势
  • 伴侣动物
    • 狗
    • 猫
    • 马匹
    • 其他伴侣动物
  • 牲畜
    • 牛
    • 猪
    • 家禽
    • 绵羊和山羊
    • 其他牲畜

第八章：市场估计与预测：按地区，2021 年至 2034 年

  • 主要趋势
  • 北美洲
    • 我们
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 荷兰
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 韩国
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿联酋

第九章：公司简介

  • Antech Diagnostics
  • Boehringer Ingelheim International
  • Colorado State University
  • GD Animal Health
  • Heska Corporation
  • IDEXX Laboratories
  • Laboklin
  • Neogen Corporation
  • Nova Biomedical
  • Thermo Fisher Scientific
  • Virbac
  • VCA
  • Vaxxinova
  • Zoetis
简介目录
Product Code: 5540

The Global Veterinary Reference Laboratory Market was valued at USD 4.9 billion in 2024 and is estimated to grow at a CAGR of 10.6% to reach USD 13.3 billion by 2034. A major driver of this growth is the rising incidence of chronic and zoonotic diseases in farm and companion animals. This increase in disease burden has sparked greater demand for diagnostic services, especially as awareness among pet owners regarding early diagnosis of conditions like diabetes, cancer, and parasitic infections continues to grow. In the livestock industry, stricter requirements around food safety and animal health are further encouraging the adoption of advanced testing services.

Veterinary Reference Laboratory Market - IMG1

Public and private investments, driven by regulatory efforts centered on improving animal health management, are fueling the development of diagnostic infrastructure. Expanding networks of veterinary diagnostic laboratories and growing collaborations between clinics and reference facilities are helping to extend services into previously underserved markets. Additionally, a rise in pet insurance coverage is making veterinary diagnostics more financially accessible to pet owners, enhancing the utilization of reference laboratory services and accelerating the market's momentum across both developed and emerging economies.

Market Scope
Start Year2024
Forecast Year2025-2034
Start Value$4.9 Billion
Forecast Value$13.3 Billion
CAGR10.6%

In 2024, the clinical chemistry segment achieved a valuation of USD 1.8 billion due to the critical role these tests play in analyzing blood and bodily fluids. These tests are essential for assessing internal organ functions, electrolyte levels, and overall metabolic status. They are particularly relevant for detecting chronic diseases such as renal disorders, diabetes, and endocrine conditions in pets and livestock. The growing use of automated, high-throughput analyzers in reference labs has helped deliver quick and accurate results, meeting the increasing demand for both routine and emergency diagnostic services.

The clinical pathology segment captured a 34.6% share in 2024 and remains a cornerstone of veterinary diagnostics. This category includes vital services like hematology, cytology, urinalysis, and chemistry-based tests that help identify various disease conditions in animals. Clinical pathology serves as the first line of evaluation in veterinary healthcare, aiding in everything from routine health monitoring to diagnosing complex illnesses. With chronic and infectious diseases becoming more common, there is heightened reliance on these tests for managing animal health across both clinical and preventive care settings.

U.S. Veterinary Reference Laboratory Market reached USD 1.7 billion in 2024. Its growth is driven by high pet ownership rates, increasing veterinary expenditures, and strong access to modern animal care services. The country's well-established veterinary infrastructure, along with the widespread adoption of pet insurance, is encouraging more frequent diagnostic testing. This environment supports the expansion of advanced reference laboratory services in the country and contributes significantly to the overall market.

Key players operating in the Global Veterinary Reference Laboratory Market include Zoetis, Heska Corporation, IDEXX Laboratories, Thermo Fisher Scientific, Antech Diagnostics (Mars), Virbac, Nova Biomedical, Vaxxinova, Boehringer Ingelheim International, Laboklin, GD Animal Health, Neogen Corporation, and Colorado State University. To strengthen their position in the veterinary reference laboratory market, companies are implementing a range of strategic initiatives. These include expanding their laboratory networks and entering strategic partnerships with veterinary clinics to boost service accessibility. Many firms are also investing in next-generation diagnostic tools and automation to deliver faster, more accurate results. Emerging markets through acquisitions and localized service offerings, allowing them to reach more customers while enhancing operational scalability.

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market scope and definition
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Data mining sources
    • 1.3.1 Global
    • 1.3.2 Regional/country
  • 1.4 Base estimates and calculations
    • 1.4.1 Base year calculation
    • 1.4.2 Key trends for market estimation
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
  • 1.6 Forecast model
  • 1.7 Research assumptions and limitations

Chapter 2 Executive Summary

  • 2.1 Industry 360° synopsis
  • 2.2 Key market trends
    • 2.2.1 Regional
    • 2.2.2 Technology
    • 2.2.3 Application
    • 2.2.4 Animal type
  • 2.3 CXO perspectives: Strategic imperatives
    • 2.3.1 Key decision points for industry executives
    • 2.3.2 Critical success factors for market players
  • 2.4 Future outlook and strategic recommendations

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
    • 3.1.1 Supplier landscape
    • 3.1.2 Value addition at each stage
    • 3.1.3 Factors affecting the value chain
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Increasing pet adoption for companionship
      • 3.2.1.2 Rising adoption of pet insurance and increasing animal health expenditure
      • 3.2.1.3 Rising number of zoonotic diseases among pet animals
    • 3.2.2 Industry pitfalls and challenges
      • 3.2.2.1 High cost associated with diagnostic services
      • 3.2.2.2 Growing demand for POC portable instruments
    • 3.2.3 Opportunities
      • 3.2.3.1 Expansion into emerging markets
      • 3.2.3.2 Increasing demand for livestock and food safety testing
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
    • 3.4.1 North America
    • 3.4.2 Europe
    • 3.4.3 Asia Pacific
    • 3.4.4 Latin America
    • 3.4.5 Middle East and Africa
  • 3.5 Technology and innovation landscape
    • 3.5.1 Current technological trends
    • 3.5.2 Emerging technologies
  • 3.6 Future market trends
  • 3.7 Porter's analysis
  • 3.8 PESTEL analysis

Chapter 4 Competitive Landscape, 2024

  • 4.1 Introduction
  • 4.2 Company market share analysis
  • 4.3 Company matrix analysis
  • 4.4 Competitive analysis of major market players
  • 4.5 Competitive positioning matrix
  • 4.6 Key developments
    • 4.6.1 Mergers and acquisitions
    • 4.6.2 Partnerships and collaborations
    • 4.6.3 New product launches
    • 4.6.4 Expansion plans

Chapter 5 Market Estimates and Forecast, By Technology, 2021 – 2034 ($ Mn)

  • 5.1 Key trends
  • 5.2 Clinical chemistry
  • 5.3 Immunodiagnostics
    • 5.3.1 ELISA
    • 5.3.2 Lateral flow assays
    • 5.3.3 Other immunodiagnostics assays
  • 5.4 Molecular diagnostics
    • 5.4.1 PCR tests
    • 5.4.2 Microarray
    • 5.4.3 Other molecular diagnostic services
  • 5.5 Hematology
  • 5.6 Urinalysis
  • 5.7 Other technologies

Chapter 6 Market Estimates and Forecast, By Application, 2021 – 2034 ($ Mn)

  • 6.1 Key trends
  • 6.2 Clinical pathology
  • 6.3 Bacteriology
  • 6.4 Virology
  • 6.5 Parasitology
  • 6.6 Productivity testing
  • 6.7 Pregnancy testing
  • 6.8 Toxicology testing

Chapter 7 Market Estimates and Forecast, By Animal Type, 2021 – 2034 ($ Mn)

  • 7.1 Key trends
  • 7.2 Companion animals
    • 7.2.1 Dogs
    • 7.2.2 Cats
    • 7.2.3 Horses
    • 7.2.4 Other companion animals
  • 7.3 Livestock animals
    • 7.3.1 Cattle
    • 7.3.2 Swine
    • 7.3.3 Poultry
    • 7.3.4 Sheep and goats
    • 7.3.5 Other livestock animals

Chapter 8 Market Estimates and Forecast, By Region, 2021 – 2034 ($ Mn)

  • 8.1 Key trends
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 France
    • 8.3.4 Italy
    • 8.3.5 Spain
    • 8.3.6 Netherlands
  • 8.4 Asia Pacific
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 South Korea
  • 8.5 Latin America
    • 8.5.1 Brazil
    • 8.5.2 Mexico
    • 8.5.3 Argentina
  • 8.6 Middle East and Africa
    • 8.6.1 South Africa
    • 8.6.2 Saudi Arabia
    • 8.6.3 UAE

Chapter 9 Company Profiles

  • 9.1 Antech Diagnostics
  • 9.2 Boehringer Ingelheim International
  • 9.3 Colorado State University
  • 9.4 GD Animal Health
  • 9.5 Heska Corporation
  • 9.6 IDEXX Laboratories
  • 9.7 Laboklin
  • 9.8 Neogen Corporation
  • 9.9 Nova Biomedical
  • 9.10 Thermo Fisher Scientific
  • 9.11 Virbac
  • 9.12 VCA
  • 9.13 Vaxxinova
  • 9.14 Zoetis